(Q32027642)

5 July 2017

title

The role of vigabatrin in childhood seizure disorders: results from a clinical audit (English)

1 reference

5 July 2017

1 reference

Prasad AN

1

1 reference

5 July 2017

Penney S

series ordinal

2

1 reference

5 July 2017

Buckley DJ

series ordinal

3

1 reference

5 July 2017

publication date

1 January 2001

1 reference

5 July 2017

1 reference

5 July 2017

volume

42

1 reference

5 July 2017

issue

1

1 reference

5 July 2017

page(s)

54-61

1 reference

MRI findings in epileptic patients on vigabatrin for more than 5 years.

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

Severe persistent visual field constriction associated with vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

Severe persistent visual field constriction associated with vigabatrin. Chronic refractory epilepsy may have role in causing these unusual lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

Low-dose vigabatrin (gamma-vinyl GABA)-induced damage in the immature rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

Effect of long-term vigabatrin administration on the immature rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

Human brain GABA levels rise rapidly after initiation of vigabatrin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

GABA changes with vigabatrin in the developing human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

Vigabatrin in intractable childhood epilepsy: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

Visual function loss from vigabatrin: effect of stopping the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

Vigabatrin (gamma-vinyl-GABA): neuropathologic evaluation in five patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

The potential for vigabatrin-induced intramyelinic edema in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.23100.X

10.1046/J.1528-1157.2001.23100.X

21 January 2018

Identifiers

DOI

1 reference

5 July 2017

1 reference